• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Therapy of coronary vasoconstriction in patients with coronary artery disease.

作者信息

Gunther S, Muller J E, Mudge G H, Grossman W

出版信息

Am J Cardiol. 1981 Jan;47(1):157-62. doi: 10.1016/0002-9149(81)90304-0.

DOI:10.1016/0002-9149(81)90304-0
PMID:6779618
Abstract

Patients with obstructive coronary artery disease and stable, exertional angina respond to the alpha adrenergic stimulus of the cold pressor test with an inappropriate increase in coronary vascular resistance. The clinical significance of this abnormal response and its possible role in the pathogenesis of ischemic heart disease are discussed. Comparison of the anti-anginal agents currently in use of undergoing investigation suggests that the calcium antagonists may be the most effective therapy for coronary vasoconstriction. Nifedipine, 10 mg buccally, successfully prevented the increase in coronary vascular resistance during the cold pressor test in 10 of 10 patients, whereas the response in placebo-treated patients was unaltered. This dose of nifedipine was without effect on systemic hemodynamics or myocardial oxygen consumption, suggesting a selective antivasoconstrictor effect on the coronary vasculature.

摘要

相似文献

1
Therapy of coronary vasoconstriction in patients with coronary artery disease.
Am J Cardiol. 1981 Jan;47(1):157-62. doi: 10.1016/0002-9149(81)90304-0.
2
Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.冠心病患者联合使用β-肾上腺素能阻滞剂和钙通道阻滞剂后的局部冠状动脉血管收缩
J Am Coll Cardiol. 1985 Jun;5(6):1438-50. doi: 10.1016/s0735-1097(85)80361-2.
3
Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease.硝苯地平对冠心病患者异常冠状动脉血管收缩的预防作用
Circulation. 1981 Apr;63(4):849-55. doi: 10.1161/01.cir.63.4.849.
4
Inappropriate coronary vasoconstriction in patients with coronary artery disease: a role for nifedipine?冠心病患者不适当的冠状动脉血管收缩:硝苯地平起作用吗?
Am J Cardiol. 1979 Oct 22;44(5):793-7. doi: 10.1016/0002-9149(79)90199-1.
5
Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs.
Am J Cardiol. 1979 Mar;43(3):647-52. doi: 10.1016/0002-9149(79)90026-2.
6
Alpha-adrenergic coronary constriction in effort angina.
Basic Res Cardiol. 1990;85 Suppl 1:359-69. doi: 10.1007/978-3-662-11038-6_29.
7
Reflex increase in coronary vascular resistance in patients with ischemic heart disease.缺血性心脏病患者冠状动脉血管阻力的反射性增加。
N Engl J Med. 1976 Dec 9;295(24):1333-7. doi: 10.1056/NEJM197612092952401.
8
Effects of cold stimulation on coronary haemodynamics during exercise in patients with coronary artery disease.寒冷刺激对冠心病患者运动期间冠状动脉血流动力学的影响。
Eur Heart J. 1985 Mar;6(3):239-46. doi: 10.1093/oxfordjournals.eurheartj.a061847.
9
[Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic].
Kardiologiia. 1988 Oct;28(10):47-51.
10
Coronary hemodynamic and metabolic effects of nifedipine in patients with coronary artery disease treated with beta-blocking drugs.
Am J Cardiol. 1985 Jan 1;55(1):33-6. doi: 10.1016/0002-9149(85)90294-2.

引用本文的文献

1
Calcium antagonists: A new class of therapeutic agents.钙拮抗剂:一类新型治疗药物。
Cardiovasc Dis. 1981 Sep;8(3):413-420.
2
Alpha- and beta-blockade in angina pectoris.心绞痛中的α和β受体阻滞剂
Drugs. 1984;28 Suppl 2:69-87. doi: 10.2165/00003495-198400282-00006.
3
Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.尼卡地平对心绞痛患者冠状动脉血流量、左心室收缩功能状态及心肌代谢的影响。
Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):147S-157S. doi: 10.1111/j.1365-2125.1985.tb05158.x.